National Bank of Canada
GDRX icon

National Bank of Canada’s GoodRx Holdings GDRX Stock Holding History

National Bank of Canada’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-301
Closed -$984K – 2912
2021
Q4 		$984K Buy
+301
New +$12.1K ﹤0.01% 1060

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

National Bank of Canada's GDRX Position: Q1 2026 in Review

National Bank of Canada reduced its GoodRx Holdings (GDRX) stake by 58% in Q1 2026, selling an estimated $17.5K and leaving 5,335 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2323.

National Bank of Canada first reported a position in GDRX in Q4 2021 and has held it in 15 quarters since. The position peaked at $984K in Q4 2021. 175 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • National Bank of Canada held 5,335 shares of GoodRx Holdings worth $10.5K as of Q1 2026.
  • National Bank of Canada sold 7,479 GoodRx Holdings shares in Q1 2026, an estimated $17.5K.
  • GoodRx Holdings made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2323 holding.
  • National Bank of Canada first reported a position in GoodRx Holdings in Q4 2021 and has held it in 15 quarters since.
  • National Bank of Canada's GoodRx Holdings position peaked at $984K in Q4 2021.
  • 175 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.